Vicarious Surgical shareholders approve 1-for-30 reverse stock split, effective June 12, 2024

Vicarious Surgical Inc.

Shareholders approved reverse stock split at ratio of 1-for-30 effective June 12, 2024.
Class A shares reduced from ~156.8M to ~5.2M; Class B from ~19.6M to ~654k.
Warrants exercisable for ~921,620 shares at $345.00 per share post-split; CUSIP changed.
2021 Equity Incentive Plan amended to increase authorized shares by 5M pre-split (166,666 post-split).
All seven director nominees elected: Adam Sachs, Sammy Khalifa, Victoria Carr-Brendel, Ric Fulop, David Ho, Beverly Huss, Donald Tang.

item 3.03 item 5.02 item 5.03 item 5.07 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.